There are several treatment options for multiple myeloma. Since this disease varies by person, the type of therapy you receive depends on factors such as your age, general health, and disease stage.

Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the soft inner part of your bones. If you ...

Multiple myeloma is a rare cancer with many treatment options, though it currently has no cure. We asked our experts at Huntsman Cancer Institute to weigh in on frequently asked questions about ...

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, ...

In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones, kidneys, ...

The BCMA protein has become the primary target for treating multiple myeloma, resulting in longer survival and more manageable side effects. For more than seven years, 58-year- old Cindy Brown of ...

Darzalex Faspro’s approval for smoldering multiple myeloma could allow for earlier intervention and reduce the risk of ...

The Huntsman Cancer Institute Bispecific Collaborative Access and Referral Network (HCI biCARE) is designed to increase patient access to bispecific antibodies (BsAbs), especially for underserved ...

During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.